Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

Rimidi Enhances Integration with Dexcom, Adds Glycemic Risk Index to Diabetes Platform

What You Should Know: Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to

June 23, 2023

Canadian wildfire smoke triggers poor air quality, health advisories in Colorado – The Cannabist

Related Articles Haze blanketed Colorado on Monday as wildfire smoke drifted from Canada, and the gray skies are expected to hover overhead for at least

July 23, 2024

Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval

Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.